Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verrica Pharmaceuticals (VRCA) Inventory (2023 - 2025)

Verrica Pharmaceuticals (VRCA) has 3 years of Inventory data on record, last reported at $2.2 million in Q4 2025.

  • For Q4 2025, Inventory fell 9.22% year-over-year to $2.2 million; the TTM value through Dec 2025 reached $2.2 million, down 9.22%, while the annual FY2025 figure was $2.2 million, 9.22% down from the prior year.
  • Inventory reached $2.2 million in Q4 2025 per VRCA's latest filing, down from $2.3 million in the prior quarter.
  • Across five years, Inventory topped out at $2.7 million in Q2 2024 and bottomed at $279000.0 in Q3 2023.
  • Average Inventory over 3 years is $2.1 million, with a median of $2.5 million recorded in 2024.
  • Peak YoY movement for Inventory: soared 826.16% in 2024, then decreased 10.84% in 2025.
  • A 3-year view of Inventory shows it stood at $1.0 million in 2023, then soared by 141.0% to $2.5 million in 2024, then dropped by 9.22% to $2.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory were $2.2 million in Q4 2025, $2.3 million in Q3 2025, and $2.5 million in Q2 2025.